Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.

ABSTRACT:

SUBMITTER: Cameron D 

PROVIDER: S-EPMC5489700 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature